Elucidation and examination of cellular subpopulations that display condition-specific behavior can play a critical contributory role in understanding disease mechanism, as well as provide a focal point for development of diagnostic criteria linking such a mechanism to clinical prognosis. Despite recent advancements in singlecell measurement technologies, the identification of relevant cell subsets through manual efforts remains standard practice. As new technologies such as mass cytometry increase the parameterization of single-cell measurements, the scalability and subjectivity inherent in manual analyses slows both analysis and progress. We therefore developed Citrus (cluster identification, characterization, and regression), a data-driven approach for the identification of stratifying subpopulations in multidimensional cytometry datasets. The methodology of Citrus is demonstrated through the identification of known and unexpected pathway responses in a dataset of stimulated peripheral blood mononuclear cells measured by mass cytometry. Additionally, the performance of Citrus is compared with that of existing methods through the analysis of several publicly available datasets. As the complexity of flow cytometry datasets continues to increase, methods such as Citrus will be needed to aid investigators in the performance of unbiased-and potentially more thorough-correlation-based mining and inspection of cell subsets nested within high-dimensional datasets.
Elucidation and examination of cellular subpopulations that display condition-specific behavior can play a critical contributory role in understanding disease mechanism, as well as provide a focal point for development of diagnostic criteria linking such a mechanism to clinical prognosis. Despite recent advancements in singlecell measurement technologies, the identification of relevant cell subsets through manual efforts remains standard practice. As new technologies such as mass cytometry increase the parameterization of single-cell measurements, the scalability and subjectivity inherent in manual analyses slows both analysis and progress. We therefore developed Citrus (cluster identification, characterization, and regression), a data-driven approach for the identification of stratifying subpopulations in multidimensional cytometry datasets. The methodology of Citrus is demonstrated through the identification of known and unexpected pathway responses in a dataset of stimulated peripheral blood mononuclear cells measured by mass cytometry. Additionally, the performance of Citrus is compared with that of existing methods through the analysis of several publicly available datasets. As the complexity of flow cytometry datasets continues to increase, methods such as Citrus will be needed to aid investigators in the performance of unbiased-and potentially more thorough-correlation-based mining and inspection of cell subsets nested within high-dimensional datasets.
informatics | biomarker discovery S ingle-cell measurements have enabled the detailed investigation of cellular function, intracellular signaling networks, immune state, and the role of specific cellular subsets in disease. Specifically, the behavior of specific cellular subpopulations (i.e., subpopulation abundance or functional activity) has been shown to serve as a surrogate marker of disease status or to predict clinical outcome in many studies (1) (2) (3) (4) (5) . Such subpopulations may be of interest for follow-up studies that aim to improve disease diagnosis or prognosis or to enable a better understanding of disease mechanism. Currently, fluorescence-based flow cytometers permit the concurrent measurement of 12-17 parameters per cell, whereas the next generation of mass cytometry platforms (CyTOF) has increased this number to >40 (6) . Additionally, multiplexing techniques such as fluorescent and mass tag cell barcoding have enabled the concurrent robust measurement of samples subjected to dozens of experimental conditions (7) .
With a continual increase in the number of simultaneously measurable parameters by flow cytometry, experimental complexity, and number of samples measured in disease studies, there is an urgent need for methods that enable intersamplegroup analyses, multivariate effects, and identification of rare cell subsets with novel behaviors. For instance, many flow cytometry experiments seek "stratifying" subpopulations of cells whose abundance or behavior is correlated with a known endpoint of interest (e.g., subpopulations whose behavior is predictive of sample disease state, sensitivity to drug therapy, or patient outcome). However, there are currently few methods for automatically identifying such relevant populations in datasets of the complexity and size that can be produced with CyTOF and related high-parameter platforms. Where-and how-in highdimensional space does one begin to search for changes induced by experimental perturbations?
Historically, approaches to identifying stratifying cellular subpopulations have relied on manual identification (gating) of cell subsets within each sample. Gating is typically followed by domain knowledge-driven quantitation and comparison of various population properties between sample groups (for instance, response to therapy or nonresponsiveness). However, manual examination is labor-intensive and has been shown to be subjective (8) , resulting in a nonexhaustive analysis that does not scale in circumstances with a large number of patient samples or experimental conditions.
Many methods have been developed that attempt to automate various stages of the manual analysis pipeline. For instance, a variety of automated gating approaches were developed to ease the bottleneck of manual gating. Methods use various strategies for identifying cell subsets, including nonparametric clustering (9) (10) (11) , model-based approaches (12) (13) (14) , density-based methods (15) (16) (17) , and combinations thereof (18). However, estimating the true number of clusters in a dataset remains a challenge for these methods (SI Appendix, Fig. S10 ), and many (i.e., binning and model-based approaches) do not scale well to higherdimensional data. Another class of methods, such as those featured in the Flow Cytometry: Critical Assessment of Population Identification Methods II (FlowCAP-II) competition, automate the task of predicting the disease state of an unanalyzed flow cytometry sample by using classification models trained on previously annotated samples (19). Many of these approaches rely on Significance Single-cell measurement technologies such as flow cytometry permit the investigation of specific cellular subpopulations. Mass cytometry currently measures >40 parameters per cell and produces phenotypically rich datasets that may be retrospectively interrogated for relevant biological signal. There are few methods that identify experimentally relevant subpopulations within these datasets, and most do not scale well to higher-dimensional measurements. To address this bottleneck, we present a data-driven method termed Citrus that identifies cell subsets associated with an experimental endpoint of interest. Citrus can test diverse experimental hypotheses and is demonstrated through the systematic identification of (i) blood cells that signal in response to experimental stimuli and (ii) T-cell subsets whose abundance is predictive of AIDS-free survival risk in patients with HIV.
nonregularized classification models such as support vector machines that are difficult to interpret. Consequently, formulation of biological hypotheses from the constructed model can be challenging. Most recently, Aghaeepour et al. described a methodtermed "flowType"-that automatically identifies subsets of cells correlated with patient outcome (20) . In their work, Aghaeepour et al. use flowType with flowMeans clustering to identify many cellular subsets in a cohort of HIV-infected patients. A Cox proportional-hazards model was then used to identify which cell subsets' abundance was correlated with patient AIDS-free survival time. For cells measured by using a panel of n markers, flowType examines all 3 n permutations of cell subsets defined by positive, negative, or neutral combinations of measured markers, making it infeasible for use with higher-dimensional datasets (i.e., 30 parameters).
To address issues of scalability, subjectivity, sensitivity, and model cell subset correlations with outcome, we developed an automated, data-driven method for identifying stratifying cell subsets (termed here as Citrus). Given cytometry data from many samples and an endpoint of interest for each sample (e.g., good or poor patient outcome, patient survival time), Citrus identifies clusters of phenotypically similar cells in an unsupervised manner, characterizes the behavior of identified clusters by using biologically interpretable metrics, and leverages regularized supervised learning algorithms to identify the subset of clusters whose behavior is predictive of a sample's endpoint. While requiring minimal expertise and input to operate, Citrus produces a list of stratifying clusters and behaviors, plots conventional biaxial or other data representations describing the phenotype of each cluster, and provides a predictive model that can be used to analyze newly acquired or validation samples. Herein, Citrus is described in the context of its application to a synthetic dataset, used to detect known biological responses in stimulated healthy blood samples after stimulation compared with control, evaluated on publicly available datasets, and compared with existing methods.
Results
Summary of Citrus. Citrus begins by identifying clusters of phenotypically similar cells in all samples in an unsupervised manner. To facilitate equal representation of samples and decrease compute time, Citrus randomly selects a user-specified number of cells from all sample files and combines them into a single representative dataset (Fig. 1, i) . Clusters of cells in the aggregate data are identified by hierarchically clustering cell events based on marker similarity (Fig. 1, ii) . Citrus is predicated on an assumption that physiologically or clinically relevant cell populations that are representative of a given phenotype will be seen as robustly recurring events in the aggregate data. Citrus by default conservatively specifies that clusters of interest must contain at least 5% of measured events. All cell clusters identified in the clustering hierarchy larger than this minimum clustersize threshold (MCST) are marked for subsequent analysis, thus permitting cells to be assigned to multiple clusters that are part of a given hierarchy (SI Appendix, section S1.2). The MCST may be changed based on prior knowledge of cellular abundances (stem cell abundance, for instance).
Citrus next splits the combined clustered data back into individual sample components and calculates features that describe each cluster on a per-sample basis. These features include the proportion of a sample's cells in each cluster, the median level of each functional marker in a cluster of cells, and the difference in these values across multiple experimental conditions (if measured) (Fig. 1, iii) .
Citrus uses regularized supervised learning algorithms to identify stratifying clusters and cell response features that are the best predictors of a known experimental endpoint of interest (Fig.  1, iv and v) . For intergroup analyses, a regularized classification model is trained to predict the known experimental group of each sample (e.g., healthy patients or diseased patients). By definition, the regularized model automatically identifies the subset of cluster features that best predict a sample's group-thus revealing clusters of cells with stratifying behaviors within the dataset. Citrus estimates, and then plots, the accuracy of the classification model via cross-validation, thus enabling the investigator to assess the quality of the results (SI Appendix, section S1.2 and Fig. S7) . The values of stratifying features are then plotted on a per-group basis (Fig. 1, vi) . The marker expression phenotype of each relevant cell cluster is then plotted (Fig. 1, vii) .
Prior knowledge suggests that most cluster-calculated features will not be good predictors of a sample's group. Accordingly, Citrus constructs classification models using the lassoregularized logistic regression and nearest shrunken centroid methods (21, 22). In general, both of these methods construct classification models from automatically selected subsets of informative features and restrict the number of model regressors by applying a regularization penalty, λ, for each feature included in the model. In practice, the number of predictive features selected by a model is inversely proportional to the regularization threshold. Because the true number of informative features in the data is unknown to the user a priori, a series of models with increasing complexity is constructed by using a range of regularization thresholds, and the error rates of these models are estimated by using K-fold cross-validation. After cross-validation, Citrus generates a plot showing the fit of all models as a function of the regularization threshold, allowing the investigator to readily identify models having a low and/or acceptable error rate. Citrus randomly selected up to 5,000 cell events from each sample based on data availability, combined them, and clustered the aggregate data based on lineage marker similarity, resulting in the identification of 75,576 cellular clusters. For this proof-ofconcept analysis, a MCST of 5% was specified, meaning that that subsets of interest must contain a minimum of 5% of measured events. This conservative threshold was selected to constrain output to a small set of results. A total of 31 clusters, each containing at least 3,700 cells (5% of the number of events in the aggregated dataset) were retained by Citrus for further analysis. Citrus characterized the behavior of each cluster by calculating cluster functional marker medians on a per-sample basis, resulting in a total of 465 descriptive cluster features for each sample.
Cluster features were used to train a nearest shrunken centroid classifier of the sample's simulation group (stimulated or unstimulated) at a range of regularization thresholds. Crossvalidation and permutation tests were used to estimate and plot the classification error rates and feature false discovery rates (FDRs) of each model, respectively ( Fig. 2A) .
To determine all cluster features that differed between stimulated and unstimulated samples, error plots produced by Citrus were used to identify the smallest regularization threshold that produced a model with perfect cross-validation accuracy and an estimated feature FDR of <1%. Citrus used this regularization threshold to constrain a final classification model constructed from all samples. From an original set of 465 cluster features, the final regularized model identified a subset of 117 that differed between the two stimulation conditions (SI Appendix, Figs. S1 and S2). Stratifying cell subsets in PBMCs. Of the 117 identified stratifying features, the median level of phosphorylated S6 in cluster 75561 was the best predictor of the sample stimulation group (Fig. 2B) . Cluster 75561 was found to be enriched for markers CD20, CD45, and HLA-DR, but not CD3, CD7, or CD4 (Fig. 2C ). This result conforms to expectations for a cell subset comprising primarily B cells; this observation was further confirmed by manual gating. As expected, activation of proteins downstream of the BCR in a population of B cells is a consequence of BCR cross-linking, thus confirming the ability of Citrus to reidentify known stratifying signals in a canonical cellular population. Compared with the expertdriven efforts of manual population identification and inspection used by Bodenmiller et al. (7) , Citrus was able to identify this relevant population and stratifying response among hundreds of potentially informative signals without prior knowledge of B-cell biology.
Further inspection of additional stratifying subsets revealed phosphorylation of S6, ERK, and PLCγ2 in B cells, as well as S6 in HLA-DR + monocytes (cluster 75560). Results were consistent with existing knowledge of intracellular signaling networks and were also reported by Bodenmiller et al. (7) . Additionally, Citrus detected an unexpected but systematic change in levels of phosphorylated NF-κB p65 in all cells and subtle but consistent differences in phosphorylated BTK and SLP76 levels in many cell populations that would not normally be expected to respond to BCR cross-linking (SI Appendix, Figs. S1 and S2). Although responses to cross-linking in BCR/FCR-expressing populations would be expected and likely identified by an investigator performing a manual analysis, the unexpected and sometimes subtle changes of phosphorylated NF-κB p65, BTK, and SLP76 levels in off-target populations could potentially go unnoticed when manually inspecting data. Validation of stratifying responses. Stratifying signals identified using Citrus were validated by measuring the effect of dasatinib, a tyrosine kinase inhibitor, on putative cross-linker-induced phosphorylation events. Additional experimental data from Bodenmiller et al., including measurements from stimulated and unstimulated samples in the presence of dimethyl-sulfoxide or dasatinib, were mapped to stratifying cell subsets identified by Citrus (SI Appendix, section S1.2). Median phosphoprotein levels in each cell subset were calculated in the presence of increasing concentrations of dasatinib (Fig. 2D) .
Dasatinib reduced levels of phosphorylated pS6, pERK, pAKT, and pPLCγ2 in B-cells (cluster 75561) and pS6 in HLA-DR + monocytes (cluster 75560) in a dose-dependent manner, confirming that phosphorylation events in these cell subsets were induced by BCR/FCR cross-linking (SI Appendix, Fig. S15 ). Levels of phosphorylated BTK, SLP76, and NF-κB p65 in offtarget populations were found to be experimental artifacts introduced by multiplexing protocols and were not affected by dasatinib. Thus, an unbiased identification of stratifying signals across all cell subsets revealed both expected biological and unexpected experimental effects. These stratifying signals could enable investigators to develop biological hypotheses for followup studies and, in this circumstance, allow the user to improve experimental protocols accordingly.
Evaluation of Citrus vs. Existing Methods. The performance of Citrus was compared with existing computational methods by way of three analyses. First, the ability of hierarchical clustering to reidentify manually gated populations was quantified in five datasets from the FlowCAP-I competition. Second, the capacity of Citrus to identify prognostic cell subsets in HIV-infected patients was compared with that of an existing analytical method, flowType. Finally, the ability of Citrus to perform binary classification of flow cytometry samples was measured in two datasets from the FlowCAP-II competition. Evaluation of hierarchical clustering performance. The capacity of Citrus to reidentify manually gated populations was quantified in five datasets from the FlowCAP-I competition (SI Appendix, Table S2 ) (19). Populations of cells in each FlowCAP-I dataset were identified by an expert using manual gating and may be used as a reference against which to evaluate the performance of a given clustering algorithm. In contrast to most existing population-finding algorithms, Citrus does not attempt to define the exact number of populations in a dataset at the time of clustering. Rather, Citrus identifies many overlapping candidate subsets that may contain informative signal and then uses regularized regression to identify those with stratifying behavior after clustering. Because all clusters in the clustering hierarchy are examined for stratifying signal, the clustering sensitivity of Citrus was quantified based on its ability to identify a manually gated population at any point in the clustering hierarchy.
The F 1 measure was used to quantify the similarity between an algorithmically defined cluster and a manually gated population of cells as described in Aghaeepour et al. (19, 24) . F 1 measures were calculated between every manually gated population and computationally identified cluster within a sample and were used to identify the cluster that best "matched" each manually gated population. The clustering's sensitivity measure was defined to be the average of F 1 measures from clusters that best matched manually gated populations (SI Appendix, section S1.4).
Hierarchical clustering was used to identify cell subsets in all FlowCAP-I dataset samples, and clustering sensitivity measures were computed for each dataset. For comparison, the same clustering sensitivity measures were computed for FlowCAP-I competition methods (Fig. 3A and SI Appendix, Fig. S9 ). Notably, the stated objective for FlowCAP-I methods was to identify the single best cluster for each cell. Conversely, hierarchical clustering has many opportunities to identify a manually gated population in a dataset. Therefore, these results are only intended to illustrate that by identifying many overlapping cell subsets, Citrus is better able to reidentify manually gated populations than methods that identify a fixed partition of the data. Additionally, plots of clustering sensitivity as a function of number of identified clusters showed that hierarchical clustering is able to achieve a majority of its sensitivity with a minimum cluster size cutoff of 1% or 0.5% in most datasets (Fig. 3B) .
Citrus trades clustering specificity for improved sensitivity by treating every identified cluster in the clustering dendrogram as an independent cell subset, rather than attempting to find a fixed height at which to cut the clustering dendrogram. In other words, Citrus increases its chances of finding informative cell subsets by deriving many overlapping cell subsets, including some that will be uninformative with respect to the experimental endpoint of interest. Although sensitivity gains at the expense of clustering specificity may not be acceptable for some analyses (i.e., when automating the reidentification of a manually defined population), data-driven exploratory analyses benefit from this tradeoff so long as relevant signal is not obscured by noise from identified, but noninformative, clusters. The relationship between clustering specificity and the power of Citrus to detect stratifying signal is discussed further in Method Sensitivity in Relationship to Analysis Parameters.
Identification of prognostic cell subsets in HIV-infected patients. The impact of clustering sensitivity in practice was assessed by comparing the ability of Citrus to identify prognostic cell subsets with that of flowType. More specifically, both methods were used to identify cell subsets associated with increased risk of AIDS onset in HIV-infected patients from the U.S. Military HIV Natural History Study (25). Data were first divided into training and testing sets (two-thirds and one-third of data, respectively). Each method was used to identify cell subsets in the training dataset, and subset abundances were quantified on a per-patient basis. AIDS-free survival risk was modeled as a function of each method's feature set by using a multivariate L1-penalized Cox proportional-hazards model. Training data were further split into 10 groups, and crossvalidated time-dependent receiver operating characteristic (ROC) curves were used to estimate each method's training model accuracy ( Fig. 4A ) (26, 27). For each method, a regularization threshold having the minimum average partial likelihood deviance across 10 cross-validation runs was used to constrain a final model built from method features. Each method's Cox model was used to predict the relative risk of AIDS-free survival in testing set patients, and prognostic performance was assessed by using time-dependent ROC curves and Kaplan-Meier plots ( Fig. 4 A-C).
Time-dependent ROC curves and Kaplan-Meier plots of testing cohort patients show the model constructed from the features of Citrus to be a more accurate predictor of AIDS-free survival risk.
Further details of factors contributing to discrepancies in model performance are provided in Discussion. During the Citrus analysis, five cell subsets were identified as prognostic in two-thirds of crossvalidation runs and were plotted to determine phenotype (Table 2 and SI Appendix, Fig. S3 ). Two clusters, 824617 and 824984, were selected by models in all 10 cross-validation runs (Fig. 4D) . The proportion of a patient's cells found in cluster 824617 was inversely correlated with AIDS-free survival risk. Cells in this cluster ex- pressed high levels of CD8, CD28, CD27, and CCR7 and low levels of CD4 and CD45RO, a phenotype of naive CD8 + T cells. This association was also detected and reported in the flowType manuscript and by Ganesan et al., who first analyzed these data by hand (4, 20) . Additionally the abundance of Ki-67 + cells (cluster 824964) was found to be positively correlated with risk of AIDS onset. This association was also reported by Ganesan et al. and Aghaeepour et al. Of the remaining clusters frequently selected during crossvalidation, two (clusters 824715 and 824971) had a phenotype of CCR7 + naive CD4 + T-cells (28), whereas the third (cluster 824823) had a similar phenotype to the Ki-67 + cluster. Although depletion of naive CD4 + T cells is known to be associated with HIV progression (29), the relationship between cells in cluster 824823 and HIV is not well characterized. However, these cell types may now be considered candidates for follow-up studies that assess their biological relevance to disease progression. Classification of samples in FlowCAP-II datasets. Lastly, the ability of Citrus to perform binary classification of samples was evaluated by using two datasets from the FlowCAP-II competition. Each FlowCAP-II dataset comprises samples from two classes of patients (i.e., healthy and diseased patients). The analysis objective within each dataset is to build a model that can be used to predict the class of a new, unlabeled sample. Each dataset is divided into a training and a testing set of samples that are used to construct and evaluate predictive models, respectively.
Citrus was used to analyze datasets from the Acute Myeloid Leukemia (AML) and HIV Vaccine Trials Network (HVTN) FlowCAP-II challenges. By using AML training data, Citrus was used to construct a classifier of AML presence. In the HVTN dataset, Citrus was used to construct a classifier of antigenstimulation groups in post-HIV vaccination T cells (SI Appendix, section S1.1). Dataset models were used to predict testing sample labels in a blinded fashion, and results were compared with true labels of test-set samples. SI Appendix, Table S3 summarizes the classification performance of Citrus in each dataset. Citrus correctly predicted 22 of 22 test-set labels in the HVTN dataset and 179 of 180 test-set labels in the AML dataset. Performance was similar to other top-performing methods in the FlowCAP-II competition, although many of those methods did not provide interpretable results (SI Appendix, Fig. S5 ). Notably, the single incorrect prediction made by Citrus in the AML dataset was in patient 340, a sample that was frequently misclassified by other algorithms in the FlowCAP-II competition. One explanation for this trend discussed by the competition organizers is that patient 340 may have had a preleukemic condition rather than AML (19).
Method Sensitivity in Relationship to Analysis Parameters. A Citrus analysis requires that investigators specify the number of cells that are selected from each sample, markers on which to perform clustering, and a MCST. To evaluate the relationship between clustering sensitivity and events selected per sample, a varying number of cells were selected per sample, the selected data were clustered, and the clustering's sensitivity measure was calculated (SI Appendix, section S1.7). Results showed that the number of events selected per sample did not have a large effect on clustering sensitivity in these datasets (SI Appendix, Fig. S11 ). However, an adequate number of cells must be clustered to ensure that subsets contain enough events to accurately estimate subset abundances and median phosphoprotein levels. By default, this parameter may be set so that that the smallest cluster included in the regression analysis contains an average of 50 cells per sample. The MCST parameter dictates the smallest cell subset included in the endpoint regression analysis. A smaller MCST will increase the number of clusters included in the regression analysis but decrease the model's power to detect more subtle effects. To assess the relationship between the MCST and the power of Citrus to detect differences between groups, iterations of the Bodenmiller PBMC analysis were run by using differing MCSTs (SI Appendix, section S1.7). Analyses that used smaller MCSTs identified signal in more rare cell subsets but had less power to resolve subsets whose behavior subtly differed between groups (SI Appendix, Table S4 ). SI Appendix, note S4.1 outlines several ways to maintain statistical power when searching for stratifying signal in rare cell subsets and offers a further discussion of how to set all parameters in a Citrus analysis.
Discussion
We present a method (Citrus) for unsupervised identification of subsets of cells in multidimensional flow cytometry whose behavior correlates with sample endpoints of interest. Citrus automates this process by applying hierarchical clustering to identify clusters of cells within a dataset, calculating descriptive features of each cluster, and then applying regularized supervised learning methods to determine which cell subsets' behavior are correlated with a sample's endpoint. The methodology of Citrus was demonstrated through the analysis of several cytometry datasets. The first dataset was PBMCs from which Citrus recovered known biological and experimentally induced responses. In HIV-infected patients, Citrus identified subsets of cells associated with AIDS-free survival risk. Finally, the clustering sensitivity and binary classification power of Citrus were evaluated with datasets from the FlowCAP competition.
Within the PBMC dataset, Citrus identified multiple subsets of cells that responded to BCR/FCR cross-linking. B cells, the primary target of the cross-linking agent, showed the strongest response to stimuli with multiple phosphoproteins in the signaling pathways downstream of the BCRs responding. Smaller but consistent responses in FCR-pathway proteins were also detected in monocytes. These phosphoprotein responses were validated by using additional kinase inhibitor experimental data from Analysis of FlowCAP-I datasets shows the hierarchical clustering used by Citrus to be at least as sensitive as existing methods when reidentifying manually gated populations. In practice, this clustering enabled Citrus to identify several cell subsets associated with AIDS-free survival in HIV-infected patients. The predictive model constructed from cell subsets identified using Citrus was found to have better performance on testing-set patients than the model constructed using subsets identified by flowType. Discrepancies in model performance are likely attributable to several factors. First, the multivariate clustering used by Citrus was able to automatically identify a rare subset of prognostically relevant Ki-67 + cells. However, this subset proved difficult for flowType's univariate clustering to identify (20). In turn, Aghaeepour et al. used manual gating to define boundaries for this cell subset in their analysis. Because these boundaries were not provided to flowType during our evaluation, the ability of Citrus to automatically detect this prognostic cell subset partially accounts for differences in the performance of each method's predictive model. Second, Citrus identified and used fewer cell subsets for modeling than flowType (316 vs. 177,147), making it easier for the penalized Cox model to detect informative signal. Because the number of cell subsets identified by Citrus is a function of minimum cluster size rather than the dimensionality of measured data, our approach will scale well to data produced by high-dimensional cytometry platforms such as CyTOF, whereas methods such as flowType will identify fewer clusters on lower-dimensionality data (SI Appendix, Fig. S8 ).
Perhaps the biggest difference between the hierarchical clustering used by Citrus and existing population-finding algorithms such as those entered in the FlowCAP-I competition is that Citrus identifies many overlapping clusters rather than defining fixed partition of the data. This approach is motivated by the fact that estimating the true number of clusters in a dataset remains a challenging issue for clustering algorithms. Indeed, the sensitivity of FlowCAP-I algorithms is higher when the number of manually gated populations is explicitly provided rather than estimated (SI Appendix, Fig. S10 ). Predictably, descriptive features derived from related cell subsets (e.g., parents and children in the clustering hierarchy) are often correlated. The regression models used by Citrus deal with these correlated features differ- ently. The multivariate L1-regularized regression model selects the most predictive feature from a set of correlated features and ignores the others, because they cannot explain any additional variance in the endpoint variable. Conversely, the nearest shrunken centroid's univariate approach evaluates the prognostic utility of each feature independently. Thus, sets of correlated features may be selected for model construction so long as they are informative by themselves. Sets of correlated features identified by either model may be visualized in the context of the clustering hierarchy to identify cell subsets with similar behavior (SI Appendix, note S4.3 and Figs. S12-S14).
Moving forward, a variety of methodological enhancements could improve the ability of Citrus to identify stratifying signals. Although Citrus currently analyzes all cell subsets in the clustering hierarchy larger than a specified size, information-theoretic approaches could be used to intelligently prune cell subsets containing redundant information before endpoint regression. The removal of such redundant features would improve the sensitivity of Citrus to subtle associations between subset behavior and experimental endpoints. Alternatively, sparse regression models such as the group lasso (30) that explicitly account for correlated features could be incorporated into the Citrus workflow, thus eliminating a need to reconcile related cell subsets after regression.
Citrus scales well to high-dimensional data and enables efficient identification of correlations between subpopulation behavior and diverse categorical or continuous sample attributes, such as copy number variation, genomic mutations, or other sample data found in the patient's clinical record. Because many candidate subsets are evaluated for stratifying signal, numerous samples are needed to differentiate stratifying signal from normal interpatient variability. Therefore, Citrus is not well suited for identifying stratifying signals in experiments having a limited number of patients in each experimental group and is not suitable for identifying differences between two patient samples. Additionally, evaluations show the hierarchical clustering used by Citrus to be a sensitive identifier of manually gated populations. However, because Citrus requires that clusters have a minimum number of cells in them to be included in an analysis, it may not be appropriate for identifying signatures in extremely rare subsets such as antigen-specific T cells.
As flow cytometry experiments become increasingly complex and the amount of metadata available for each sample grows (e.g., other experimental measures or rich patient history), automated methods will greatly aid investigators in the identification of informative populations of cells whose behavior is predictive of experimental or clinical endpoints. Although this work demonstrates Citrus through analysis of mass and fluorescence-based cytometry data, it is also generally applicable to many data types, including multiparameter image cytometry data. Although results always rely on the presence of discerning markers within samples, an unbiased, but more comprehensive, approach to data analysis should aid investigators in the exploration of increasingly complex flow cytometry datasets.
Materials and Methods
SI Appendix, section S1.1 lists analyzed datasets and data preprocessing steps. SI Appendix, section S1.2 details analytical steps of Citrus. Supporting figures and tables for presented analyses along with additional analysis details are found in SI Appendix, sections S2, S3, and S4, respectively. Code, documentation, and examples for running Citrus are available at https:// zenodo.org/record/10310. org/105/v2. Debris were removed prior to analysis as described in [1] . In accordance Supplementary Figure  S2 of [2] , all analyzed markers were transformed using the arcsin-hyperbolic transformation with a cofactor of 5 before analysis.
FlowCAP-I Datasets
FlowCAP-I datasets were downloaded from http://flowcap.flowsite.org/Availability.html. Data were transformed and cleanup gates were applied by competition organizers prior to download.
United States Military HIV Natural History Study
There is substantial variation in time to AIDS development among HIV-infected patients. Thus, it would be useful to identify markers of high-risk individuals who would benefit from early initiation of highly active antiretroviral therapy (HAART). The United States Military HIV Natural History Study, a prospective observational cohort of HIV-infected patients, measured estimated HIV seroconversion dates and AIDS acquisition dates for enrolled subjects. A subset of 466 patients had PBMC's collected within 18 months of their estimated seroconversion. All samples were measured by florescence-based flow cytometry using markers KI67, CD3, CD28, CD45RO, CD8, CD4, CD57, VIVID / CD14, CCR5, CD19, CD27, CCR7, and CD127.
Flow cytometry samples and patient metadata was downloaded from http://flowrepository.org/id/ FR-FCM-ZZZK. Compensation was applied and samples were singlet, viability, and CD3 + -gated as described in [3] . Samples having fewer than 3,000 CD3
+ events or a negative reported AIDS-acquisition time were discarded, leaving 416 patients for analysis. These remaining patients were partitioned into training (275 patients) and testing (141 patients) cohorts for model training and evaluation respectively. All measurements were standardized with µ = 0 and = 1 on a per-marker basis prior to clustering.
FlowCAP-II Datasets
FlowCAP-II datasets were downloaded from http://flowcap.flowsite.org/Availability.html. 
S1.2.2 Identification of Phenotypically-Similar Cells Using Hierarchical Clustering
N training samples are collected from patients and are measured by flow cytometry. An equal number of events (or a subset of events) from all samples are randomly selected and combined (Fig. 1, i ) and clustered using agglomerative hierarchical clustering (Fig. 1, ii) , producing groups of phenotypically similar cells. The dissimilarity between any two cells is specified by Euclidean distance between clustering markers and Wards linkage used as the agglomeration method. Rather than cutting the dendrogram at a fixed height to identify clusters, all clusters C in the hierarchy of merged clusters larger than a user-specified size are retained for subsequent analysis.
S1.2.3 Calculation of Descriptive Cluster Statistics
After clustering the aggregated data, cells from all samples are now assigned to one or more clusters that are comparable between samples. Next, the following F cluster features are calculated for every cluster, on a per-sample basis (Fig. 1, iii ):
• The percentage of a sample's cells that are assigned to that cluster.
• The median value of each functional marker for a sample's cells in that cluster.
If each sample has been measured in a basal state and under one or more perturbed conditions, the following additional metrics may also be calculated for each cluster:
• The di↵erence in cluster abundance between the basal and perturbed states.
• The di↵erence in cluster functional marker median values between the basal and perturbed states. unstimulated state.
This results in a N ⇥ (F*C ) matrix of cluster features with each row corresponding to a sample and each column describing a single property of a cluster in that sample (Table S1 ).
S1.2.4 Model Construction: Classification
When identifying cluster features that di↵er between sample groups, each sample is assigned by the user as belonging to one of two or more groups (Fig. 1, iv) . Next, regularized classification models are constructed with calculated cluster features acting as regressors of sample group. Importantly, prior knowledge suggests that only a subset of calculated cluster features will be useful in di↵erentiating sample groups. For this reason, classification models are constructed using the nearest shrunken centroid and lasso-regularized logistic regression methods, both of which build a series of predictive model using automatically selected informative subsets of supplied regressors. The number of features included in any give model is limited by a regularization threshold, . As it is unknown which subset of cluster features best stratify the user-specified sample group, a set of i models are built using a range of i regularization thresholds, 1 ... i . The optimal model from this set is then selected by performing cross validation on all models and then selecting the simplest one that meets user accuracy constraints.
S1.2.5 Model Construction: Survival regression
When identifying cluster features predictive of sample survival time, the survival time and censoring status for each sample is specified by the user (Fig. 1, iv) . Next, many lasso-regularized Cox proportional-hazards models are constructed with calculated cluster features acting as regressors of sample survival time. The number of features included in any give model is limited by a regularization threshold, . As it is unknown which subset of cluster features best predict patient risk, a set of i models are built using a range of i regularization thresholds, 1 ... i and evaluated using K-fold cross validation. The regularization threshold producing the model with the best total goodness of fit (as described in section S1.2.8) is used to constrain the final model.
S1.2.6 Analysis of a new sample
To predict the group of a new, unlabeled sample using a model constructed from training data, the same cluster statistics used to build the initial model must first be calculated for the new sample. Before this can be done, cells from the new sample must be first mapped to the clusters identified in the training data. This is done by taking a random subset of cells (preferably the same number drawn from each training sample) from the new sample and identifying the nearest neighbor of each in the training data by Euclidean distance. Then, cells from the new sample are assigned to all clusters of their nearest neighbor in the training data. After cluster assignments have been made, the previously described cluster statistics are calculated for the new sample and the existing model is used to predict its phenotypic class or relative survival risk.
S1.2.7 Selection of an optimally regularized model: Classification
To identify an optimal model regularization thresholdˆ , a set of predictive models is constructed using a fixed range of regularization thresholds 1 ... i , each having an di↵ering level of complexity and accuracy. Internal K -fold cross-validation is used to estimate the model error rate at each regularization threshold (Fig. 1, v) . Cross validation is performed by assigning samples randomly to K groups. Samples from all but one of the groups are used to build models at fixed range of i regularization thresholds as described in sections S1.2.2, S1.2.3, and S1.2.4. Class labels of samples in the left-out group are then predicted as described in section S1.2.6 using models at every regularization threshold. This process is repeated for all K groups, resulting in class predictions for all samples at each regularization threshold. The predicted class of each sample is compared to its true class, providing an estimated model error rate for each threshold.
S1.2.8 Selection of an optimally regularized model: Survival regression
To identify an optimal model regularization thresholdˆ , a set of predictive models is constructed using a fixed range of regularization thresholds 1 ... i . Samples are partition into K groups and the goodness of fit of each model was calculated as described by Simon et al. (Fig. 1, v) [5] . In more detail, samples are assigned randomly to K groups. Samples from all but the K'th group are used to build models at fixed range of i regularization thresholds as described in sections S1.2.2, S1.2.3, and S1.2.5. The goodness of fit for the K'th part and regularization threshold i is defined asĈV
k is the log-partial likelihood of the model excluding part K of the data and k ( i ) is the optimal for the non-leftout data. The total goodness of fitĈV ( i ) for a given i is the sum of all totalĈV k ( i ). The regularization thresholdˆ maximizing this total goodness of fit is selected to constrain the final model.
S1.2.9 Result Assessment & Selection of a Final Regularization Threshold
Model error rate plots should be used to assess the quality of results. If a constructed model has small estimated error rate, it necessarily follows that this model has identified some subset of cluster features that are robust predictors of a sample's class. These features, in turn, have a behavior that is unique for that class and are hence, stratifying subsets of interests. Conversely, if a model has a high error rate, it's likely that the features selected by the model do not consistently di↵er between sample classes and hence, are not useful stratifying features. Thus, users should interpret features and clusters only from models having an acceptable error rate. Examples of models having low (good) and high (bad) cross validation error rates and corresponding features from each shown in Figure S7 . The same interpretation holds for the survival regression case, excepting that the model fit is evaluated by its partial likelihood deviance and features selected by the model are predictive of a patients survival risk.
When one or more models with acceptable error/likelihood deviance rates have been constructed, a user must choose a regularization threshold that will be used to constrain the final model constructed from all sample features. When seeking to identify the smallest but most informative subset of features that di↵er between between classes, the regularization thresholdˆ resulting in the simplest model with an acceptable error rate should be selected. When seeking to identify many or all features di↵erentially expressed between sample classes, a regularization constraint should be selected that produces the most complex model with an acceptable estimated error and feature false discovery rate. The estimated feature false discovery rate for the nearest shrunken centroid model is calculated as follows:
For each regularization threshold i used in cross validation:
1. Randomize the class labels assigned to each sample.
2. Train a new model m i , constrained by i , to predict randomized labels from step 1.
3. Count the number of non-zero features in m i .
Steps 1-3 are repeated 1,000 times, producing a distribution of estimated of feature false discovery rates for each regularization threshold. A final model regularization thresholdˆ with an acceptable median false discovery rate is then selected and used to constrain a final model constructed from all sample features.
S1.2.10 Interpretation of Results
Nonzero features of the final model, as determined by the regularization parameterˆ , are the set of population features that best di↵erentiate sample groups or predict patient survival risk. For inter-group analyses, the values of these relevant features for each sample are shown in box plots, plotted, grouped by class (Fig.  1, vi) . For survival regression, stratifying features are plotted as a function sample survival time. Equally important as the identified stratifying features are the phenotypes of corresponding clusters. To determine cluster phenotype of any single cluster, densities plots or scatter plots of lineage markers in cluster cells are shown, along with plots of the same markers in all cells, permitting an investigator to see comparatively how much each marker is enriched in cluster cells (Fig. 1, vii) . Related stratifying subsets that have similar behavior may be identified by highlighting relevant subsets in plots of the clustering hierarchy (Note S4.3).
S1.3 Validation of Stratifying Signals in PBMCs
In addition to measuring PBMC's from 8 di↵erent patients under 12 stimulation conditions, Bodenmiller et al. also measured PBMC's from a single patient under 12 di↵erent stimulation conditions in the presence of increasing concentrations of 27 di↵erent inhibitors. Cells from unstimulated and BCR-stimulated samples in the presence of no inhibitor, DMSO, and varying concentrations of Dasatinib were mapped to clusters of interest as described in Section S1.2.6. Median levels of functional markers were calculated from cells in clusters of interest on a per sample basis. Functional markers levels were plotted for each cluster and experimental condition (Fig. S15) .
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S1.4 Quantification of Clustering Sensitivity
S1.4.1 The F 1 measure
For a given subset of cells c a identified a clustering algorithm and subset of cells c m identified by manual gating, the F 1 score measures the overlap between c a and c m . F 1 measure values range from 0 to 1 with a 1 indicating that cells assigned to c a by an algorithm are the same cells that were assigned to c m by manual gating. The F 1 -measure is the harmonic mean of a clustering's precision and recall and its use as a metric for evaluating clustering performance was described by Aghaeepour et al. [7] . The formal definition of the F 1 -measure is:
where P and R represent the precision and recall for a single cluster respectively. For clustered cells, c a , and manually gated cells c m , precision measures the proportion of cells in c a that are comprised of cells from c m .
Recall measures the proportion of cells in c m that were found in c a . Alternatively:
and
S1.4.2 Measuring Clustering Sensitivity: Scoring Algorithm Clusters vs. Manually-Defined Populations In a Single Sample
If a single sample contains a set of n manually gated populations P = {p 1 , p 2 , ..., p n } and a clustering of that same data produces a set of m clusters C = {c 1 , c 2 , ..., c m }, the sensitivity of the clustering is defined as:
In words, for a manually-defined population p i , the F 1 score is calculated for all m identified clusters and the maximum of those m measures is reported as the F 1 measure for that population. Maximum F 1 scores are calculated for all n manually gated populations and the sensitivity of a clustering is the average of those scores. Notably, this approach di↵ers from that reported by Aghaeepour et al. who weighted F 1 measures by population size. Specifically, the unweighted approach employed here better reflects algorithm performance on smaller, more rare populations of cells.
S1.4.3 Measuring Clustering Sensitivity Across Many Samples
Each FlowCAP-I Dataset D consists of S D samples with many populations of cells gated within each sample. The sensitivity measure of a clustering of dataset D is defined as:
Here, |S p | represents the total number of manually gated populations found in all samples of dataset D. In words, for a given sample s k 2 S D , the maximum F 1 score is computed for all manually gated populations P k found in s k . The average of all maximum F 1 scores from every manually gated population in every sample is reported as the dataset-specific clustering sensitivity score.
S1.4.4 Sensitivity Measures of Hierarchical Clustering on FlowCAP-I datasets
Hierarchical clustering using Euclidean Distance and Ward's linkage method was run on each FlowCAP-I dataset. Dimensions used for clustering are listed in (Table S2 ) and up to 10,000 events were selected for clustering from each sample. The minimum cluster size was set at 0.5% of the number of clustered events. Sensitivity measures were computed for each dataset as described above.
S1.4.5 Sensitivity Measures of FlowCAP-I measures on FlowCAP-I datasets
Clustering assignments from FlowCAP-I competition methods were downloaded from the FlowCAP-I website (http://flowcap.flowsite.org/Availability.html). Using supplied clustering assignments, clustering sensitivity measures were computed as described above.
S1.4.6 Sensitivity Measures in Rare Populations
To evaluate clustering performance on rare populations of cells, sensitivity measures were calculated only for hand-gated populations that contained fewer than 5% of a sample's total events. Results are shown in Figure S9 .
S1.5 Identification of Prognostic Cell Subsets in HIV-infected Patients
Data from the United States Military HIV Natural History Study was analyzed using Citrus and flowType.
Prior to analysis, data were partition into training and testing-set cohorts, balanced by the number of AIDS events in each cohort. Cell subsets in training data were identified using Citrus and flowType and used to train a model AIDS-free survival risk. AIDS-free survival risk was then estimated in testing-set patients using method models, enabling a comparison of model prognostic performance.
S1.5.1 Identification of Cell Subsets Using Citrus
Up to 3,000 cells were selected from training set samples sample and combined together for clustering. Cells were clustered based on the expression the following markers: KI67, CD3, CD28, CD45RO, CD8, CD4, CD57, VIVID / CD14, CCR5, CD19, CD27, CCR7, and CD127. Cluster abundances were calculated on a per-sample basis and clusters having an average abundance above 0.5% of events per sample were retained for further analysis. Cluster abundances from training-set samples were used to train a model of AIDSfree survival risk. To calculate testing set features, up to 3,000 cells from testing samples were mapped to training-set clusters as described in Section S1.2.6. After mapping testing data to training clusters, cluster abundances were calculated for testing patients. Cluster abundances from testing set patients were used to evaluate the performance of the survival risk model.
S1.5.2 Identification of Cell Subsets Using flowType
flowType was used to identify cell subsets in each sample (testing and training). Cells were partitioned using the following markers: KI67, CD28, CD45RO, CD8, CD4, CD57, CCR5, CD19, CD27, CCR7, and CD127. Cells were pre-gated on markers CD14/VIVID and CD3 prior to analysis and were not used for phenotype identification as the number of identified phenotypes would increase from 177,147 to 1,594,323 and L1-regularized Cox proportional-hazards model could not be fit on a feature set of this size using the R glmnet package. Partition boundaries were determined using the flowMeans method. Cell abundances from training set patients were used as train a model of AIDS-free survival risk. Cluster abundances from testing-set patients were used to evaluate the performance of the survival risk model
S1.5.3 Modeling of AIDS-Free Survival Risk
Training features were used to construct many L1-penalized Cox proportional-hazards models of AIDS-free survival risk at a range of regularization thresholds. 10-fold cross validation was used to select an optimal regularization thresholdˆ . For each fold of cross validation, fold features were used to train a series of L1-penalized Cox proportional-hazards models and the partial likelihood deviance of each was calculated a fixed range of regularization thresholds. Additionally, the predicted relative risk of left-out patients was calculated for each threshold. This operation was repeated for all 10-folds. Partial likelihood deviances at each regularization threshold were averaged across 10 patients. A final regularization thresholdˆ was selected that had the minimum average partial likelihood deviance across all 10 cross-validation folds. Patient risk estimated by cross-validation models constrained byˆ was used to assess training model performance. A final predictive model constrained byˆ was constructed from all training patient data and used to estimate the relative risk of patients in testing-set patients.
S1.5.4 Model evaluation
Time-dependent ROC curves were used to quantify model performance on training-set and test-set predictions. For training-set data, ROC curves were constructed from estimations of relative training patient risk quantified during cross-validation. For testing-set data, ROC curves were constructed from estimations of relative testing patient risk made using the final predictive model constructed from all training patient data.
Briefly, a time-dependent ROC curve is constructed at a landmark time t and has sensitivity and specificity measures of Pr[M > c|T < t] and Pr[M < c|T > t] respectively where M is the marker of interest (predicted patient risk), T is survival time and c is the threshold of positivity [6] . Time-dependent ROC curves and estimated confidence intervals were calculated using the timeROC package for R, version 0.2 (http://cran.rproject.org/web/packages/timeROC/). Sensitivity and specificity were calculated at t = 1025 days, the mean event-free survival time of all patients.
Testing-set patients were assigned into high and low-risk groups if their predicted relative risk was higher than the mean relative risk for all testing patients and vice versa. Kaplan-Meier curves were constructed for high and low risk groups and the significance of di↵erences between group curves was computed using the log-rank test. All calculations were performed using the survival package for R, version 2.37-4.
S1.5.5 Reporting of Model Features
Robust prognostic cell subsets were identified by recording the number of times each cell subset was included in the 10 L1-penalized Cox proportional-hazards models constructed during cross-validation. Cell subsets that were selected by models in more than two-thirds of models were reported as prognostic subsets of interest.
S1.6 Classification of Samples in FlowCAP-II Datasets
Datasets from the FlowCAP-II competition were used to evaluate the classification performance of Citrus. Each dataset consisted of labeled training data and unlabeled testing data. The objective of each challenge was to construct a classification model using training data and then predict the labels of testing data. Data are fully described by Aghaeepour et al. [7] . Citrus was applied to each dataset and performance was quantified using precision, recall, accuracy, and F-measures as described in [7] .
S1.6.1 Challenge 2: AML
Samples were each measured using 7 di↵erent panels of markers. Data from each panel was analyzed independently. For a given panel, 2,500 cells were selected from panel training samples and combined, producing a total of 447,500 cells. Combined events were clustered using all measured markers including forward and side-scatter channels and subset abundances were calculated on a per-sample basis. Cell subsets containing at least 4,475 events (1% of the clustered dataset size) were retained for further analysis. Panel subset abundances were used to train L1-regularized logistic regression models of sample disease state (AML present or absent) at a range of regularization thresholds. Ten-fold cross validation was used to evaluate model accuracy at each regularization threshold. A final regularization threshold ( 1se ) was selected that had an error rate within 1 standard error of the minimum cross-validation threshold. Error rates for panel models were estimated using 10-fold cross validation (Fig. S4) . The model constructed from cell subsets identified by panel 4 had the lowest estimated error among all panels. A final model constrained by 1se was constructed from all training samples measured using panel 4.
To estimate the disease status of testing-set samples, 2,500 cells were selected from each testing sample and mapped to the training clusters as described in section S1.2.6. Cluster abundances were calculated on a per-sample basis and the panel 4 classification model was used to predict the disease status of testing-set samples.
S1.6.2 Challenge 3: HVTN
Up to 10,0000 cells were selected from ENV and GAG-stimulated patient samples and combined, resulting in a total of 540,000 combined cells. Combined events were clustered using lineage markers CD3, CD4 and CD8 and subset abundances were calculated on a per-sample basis. Cell subsets containing at least 2,700 events (0.5% of the clustered dataset size) were retained for further analysis. Subset abundances were used to train L1-regularized logistic regression models of sample stimulation group (ENV or GAG) at a range of regularization thresholds. Ten-fold cross validation was used to estimate the model error rate at each regularization threshold. The regularization threshold 1se from the model with an error rate within 1 standard error of the minimum model was selected to constrain a final model constructed from all training samples.
To estimate the sample stimulation group of testing set samples, 10,000 cells were selected from each testing sample and mapped to the training clusters as described in section S1.2.6. Cluster abundances were calculated on a per-sample basis for testing set samples. The final classification model constructed from training set samples was used to predict the likelihood of GAG stimulation for testing patient sample pair. Of the two samples measured in a patient, the one having the highest predicted likelihood of GAG stimulation was labeled as such and the other was assigned the ENV label.
S1.7 Citrus Sensitivity Analysis
S1.7.1 Clustering Sensitivity As A Function Of Cells Selected Per Sample
Citrus selects and combines together an equal number events from each biological sample in order to ensure that each sample is equally represented in the clustered data. To evaluate the e↵ect of number of events selected per sample on a clustering's sensitivity measure, a varying number of events was selected and combined from each sample, clustered, and the clustering's sensitivity measure was calculated for each dataset from the FlowCAP-I competition ( Fig. S11) . The maximum di↵erence between any two clustering sensitivity measures run with di↵erent sample sizes was found to be 0.061. The average maximum di↵erence across all FlowCAP-I datasets was found to be less than 0.02. This supports the conclusion that clustering performance is largely not a↵ected by events selected per sample and recommend using 10,000 events as a default. Notably, in circumstances where the number of events to be selected from each sample was greater than the number of measured events in a sample, all cells from the sample were included but events were not included multiple times in order to reach the desired sample size. Thus, sampling larger numbers of events (i.e. 20,000 events) in datasets with a smaller number of measurements per sample will have no e↵ect on a clustering's sensitivity measure.
S1.7.2 Stratifying Subsets Detected As A Function Of MCST
When running a Citrus analysis, investigators may specify the MCST based on a combination of prior biological knowledge and the number of events the select from each sample. Setting a smaller MCST includes smaller (but does not remove larger) clusters from an endpoint regression analysis. In other words, all features from an analysis run with a larger MCST analysis are included in an analysis having a smaller MCST.
In an experiment having adequate statistical power, all stratifying features identified in an analysis run with a larger MCST would be identified in an analysis run using a smaller MCST. In practice however, the increased number of cluster features included in the regression model weakens the model's power to detect stratifying features due to corrections for multiple hypothesis testing and limited availability of samples.
The relationship between the MCST and Citrus' power to detect stratifying cell subsets was evaluated in the Bodenmiller PBMC dataset. Data were clustered as described in Section 2.2. Descriptive cluster properties were calculated for that clustering using MCST's of 5.0%, 2.5%, 1%, 0.75%, and 0.5%. Smaller MCST's were not included due to limited number of cells measured in some samples. The median expression of non-experimentally biased functional markers was calculated for cell subsets at each MCST. Subset descriptive properties calculated using di↵erent MCST's were used as regressors of sample stimulation group and stratifying cell subsets were identified as described in Section 2.2. The relationship between the MCST and Citrus' ability to detect stratifying cell subsets was measured by quantifying the proportion of stratifying cell subsets identified by an analysis run using a larger MCST that were reported by an analysis run using a smaller MCST (Table S4) . As a general trend, analyses run using smaller MCST's identify more-rare stratifying cell subsets but lose power to detect more subtle di↵erences between sample groups. Approaches described in SI Appendix S4.1 could help limit this sensitivity loss in future analyses. 
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S3 Supplemental Tables
Data Preprocessing
Prior to analysis with Citrus, data should be cleaned and transformed in a manner that is consistent with standard manual analyses. For example, doublets and debris should be removed using scatter channels, dead cells removed using a viability marker, and data transformed using the logicle or other appropriate transformation. Additionally, if measured markers have di↵erent dynamic ranges, measurements may be standardized on a per-marker basis to ensure that each marker has an equal influence on clustering.
If analysis is to be restricted to a particular lineage of cells based on existing biological knowledge, cells from other lineages should be removed. If looking for responses in subsets of T-cells for instance, non T-cells should be gated and removed prior to analysis as this will reduce clustering time and increase statistical power to detect relevant populations within the T-cell compartment. See further comments in the section on setting the minimum cluster-size threshold.
Number of Cells Selected Per Sample
Citrus selects and combines an equal number of cells from each sample for analysis. Notably, the clustering sensitivity does not appear to be greatly a↵ected by the number of events selected per sample (Fig. S11) . However, descriptive statistics that are derived from clusters may have low precision if the number of cells in a cluster is small. For instance, the precision of a median phosphoprotein measure for a cell subset is likely poor if the subset contains only 5 cells. Thus, selecting more events per sample is likely to lead to more stable estimates of clusters features. As a default, Citrus selects 5,000 events per sample. However, one should adjust this number based on their minimum cluster size of interest. As a general rule, one can select a number of events per sample such that the minimum cluster of interest will have on average, 50 events. Thus, if considering a minimum cluster-size threshold of 1%, one would select 5,000 events per sample. Selection of more events per sample results in longer analysis runtimes as clustering runtime is a function of the number of events that must be clustered. More information on the runtime of clustering may be found on the Citrus GitHub page.
Choosing Clustering Markers
For common usage, one may cluster cells by the same markers that would be used to gate the data by hand. In many scenarios, this will simply be cell surface markers. However, if there are additional functional markers that also distinguish subpopulations of cells (i.e. activated B-Cells), one may cluster on those markers as well. In this scenario, abundance features would be used to measure the presence or absence of cells defined by such functional markers.
Selecting a minimum cluster-size threshold
The minimum cluster-size threshold (MCST) parameter controls the number of cell subsets included in the endpoint regression analysis. This parameter is expressed as a percentage of the number of total cells that have been clustered. An MCST of 1% specifies that a cluster must contain at least 1% of the total clustered events in order to be included in the regression analysis. Citrus specifies a very conservative default value of 5% although this value should be adjusted based on the number of cells selected per sample for clustering and existing biological knowledge.
Setting a large MCST will result in fewer cell subsets being included in the regression analysis, but will exclude more rare cell subsets. Setting a small MCST will include more rare subsets in the regression analysis but decrease statistical power. To optimize statistical power when searching for signal in many and/or cell subsets, users may either include more samples in the analysis or limit the number of features that are included in the regression analysis. There are several strategies for the latter approach that make use of existing biological knowledge. First, if the investigator has prior knowledge that suggests that the informative cell subset is rare, Citrus may be instructed to ignore more abundant subsets (i.e. cell subsets that contain more than 5% of cells). Additionally, if prior knowledge suggests that informative signal lies within particular lineages of cells (i.e. T-Cells), all non T-Cells may be removed from the dataset prior to analysis and a larger MCST may be used.
Selecting a classification model
Users may choose to build regression models using either or both of the nearest shrunken centroid and lassoregularized regression methods. Importantly, the former employs univariate approach for classification while the latter uses a multivariate regression model. In other words, the nearest shrunken centroid approach evaluates the prognostic utility of each feature independently while the regularized regression approach builds a model based on a combination of signals found in di↵erent cell subsets. Accordingly, the nearest shrunken centroid method should be used when seeking to identify all clusters whose behavior di↵ers between samples. Conversely, the L 1 -regularized regression model should be used when identifying clusters that are combinatorially informative. The L 1 -regularized regression model may also be used to identify cell subsets that are prognostic of continuous or time-valued clinical endpoints.
Evaluation of Results
Citrus estimates model accuracy using cross validation. Users may use these plots to assess the quality of results reported by Citrus. If a model has low cross-validation error, the user may have confidence that the cell subsets identified by Citrus have a unique behavior within each sample group. Examples of good and poor cross-validation results along with accompanying features are shown in Figure S7 . 
S4.3 Note: Visualization of Subsets of cells that exhibit similar behavior
Sets of correlated descriptive cluster properties may be derived from related cell subsets that have similar behavior. To enable the investigator to quickly identify which cell subsets display similar behavior, Citrus plots the clustering hierarchy and highlights stratifying cell subsets with similar responses. Fig. S12A shows an example of such a plot from a Citrus analysis of the Bodenmiller PBMC dataset with an MCST of 1.0%. Additionally, hierarchy clusters may be colored by the median value of a lineage marker in that cluster, providing investigators with an another means for determining the phenotype of stratifying clusters (Fig.  S12B) . Figures S13 and S14 show hierarchy plots for all detected stratifying biological features and expression of all clustering markers respectively.
